Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

A. K. Berner, O. Brouwers, R. Pringle, I. Klaassen, L. Colhoun, C. McVicar, S. Brockbank, J. W. Curry, T. Miyata, M. Brownlee, R. O. Schlingemann, C. Schalkwijk, A. W. Stitt

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Aims/hypothesis: Methylglyoxal (MG) is an important precursor for AGEs. Normally, MG is detoxified by the glyoxalase (GLO) enzyme system (including component enzymes GLO1 and GLO2). Enhanced glycolytic metabolism in many cells during diabetes may overpower detoxification capacity and lead to AGE-related pathology. Using a transgenic rat model that overexpresses GLO1, we investigated if this enzyme can inhibit retinal AGE formation and prevent key lesions of diabetic retinopathy. Methods: Transgenic rats were developed by overexpression of full length GLO1. Diabetes was induced in wild-type (WT) and GLO1 rats and the animals were killed after 12 or 24 weeks of hyperglycaemia. N ε-(Carboxyethyl)lysine (CEL), N ε-(carboxymethyl) lysine (CML) and MG-derived-hydroimidazalone-1 (MG-H1) were determined by immunohistochemistry and by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MSMS). Müller glia dysfunction was determined by glial fibrillary acidic protein (GFAP) immunoreactivity and by spatial localisation of the potassium channel Kir4.1. Acellular capillaries were quantified in retinal flat mounts. Results: GLO1 overexpression prevented CEL and MG-H1 accumulation in the diabetic retina when compared with WT diabetic counterparts (p<0.01). Diabetes-related increases in Müller glial GFAP levels and loss of Kir4.1 at the vascular end-feet were significantly prevented by GLO1 overexpression (p<0.05) at both 12- and 24-week time points. GLO1 diabetic animals showed fewer acellular capillaries than WT diabetic animals (p<0.001) at 24 weeks' diabetes. Conclusions/interpretation: Detoxification of MG reduces AGE adduct accumulation, which, in turn, can prevent formation of key retinal neuroglial and vascular lesions as diabetes progresses. MG-derived AGEs play an important role in diabetic retinopathy.

Original languageEnglish (US)
Pages (from-to)845-854
Number of pages10
JournalDiabetologia
Volume55
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Pyruvaldehyde
Pathology
Transgenic Rats
Glial Fibrillary Acidic Protein
Diabetic Retinopathy
Neuroglia
Lysine
Enzymes
Retinal Vessels
Wild Animals
Potassium Channels
Tandem Mass Spectrometry
Liquid Chromatography
Hyperglycemia
Blood Vessels
Retina
Immunohistochemistry

Keywords

  • AGEs
  • Diabetic complications
  • Diabetic retinopathy
  • Glyoxalase 1
  • Methylglyoxal
  • Pathogenesis
  • Retina

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Berner, A. K., Brouwers, O., Pringle, R., Klaassen, I., Colhoun, L., McVicar, C., ... Stitt, A. W. (2012). Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia, 55(3), 845-854. https://doi.org/10.1007/s00125-011-2393-0

Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. / Berner, A. K.; Brouwers, O.; Pringle, R.; Klaassen, I.; Colhoun, L.; McVicar, C.; Brockbank, S.; Curry, J. W.; Miyata, T.; Brownlee, M.; Schlingemann, R. O.; Schalkwijk, C.; Stitt, A. W.

In: Diabetologia, Vol. 55, No. 3, 03.2012, p. 845-854.

Research output: Contribution to journalArticle

Berner, AK, Brouwers, O, Pringle, R, Klaassen, I, Colhoun, L, McVicar, C, Brockbank, S, Curry, JW, Miyata, T, Brownlee, M, Schlingemann, RO, Schalkwijk, C & Stitt, AW 2012, 'Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology', Diabetologia, vol. 55, no. 3, pp. 845-854. https://doi.org/10.1007/s00125-011-2393-0
Berner, A. K. ; Brouwers, O. ; Pringle, R. ; Klaassen, I. ; Colhoun, L. ; McVicar, C. ; Brockbank, S. ; Curry, J. W. ; Miyata, T. ; Brownlee, M. ; Schlingemann, R. O. ; Schalkwijk, C. ; Stitt, A. W. / Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. In: Diabetologia. 2012 ; Vol. 55, No. 3. pp. 845-854.
@article{01e5f9d0f8e34303838161a43f00fc0a,
title = "Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology",
abstract = "Aims/hypothesis: Methylglyoxal (MG) is an important precursor for AGEs. Normally, MG is detoxified by the glyoxalase (GLO) enzyme system (including component enzymes GLO1 and GLO2). Enhanced glycolytic metabolism in many cells during diabetes may overpower detoxification capacity and lead to AGE-related pathology. Using a transgenic rat model that overexpresses GLO1, we investigated if this enzyme can inhibit retinal AGE formation and prevent key lesions of diabetic retinopathy. Methods: Transgenic rats were developed by overexpression of full length GLO1. Diabetes was induced in wild-type (WT) and GLO1 rats and the animals were killed after 12 or 24 weeks of hyperglycaemia. N ε-(Carboxyethyl)lysine (CEL), N ε-(carboxymethyl) lysine (CML) and MG-derived-hydroimidazalone-1 (MG-H1) were determined by immunohistochemistry and by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MSMS). M{\"u}ller glia dysfunction was determined by glial fibrillary acidic protein (GFAP) immunoreactivity and by spatial localisation of the potassium channel Kir4.1. Acellular capillaries were quantified in retinal flat mounts. Results: GLO1 overexpression prevented CEL and MG-H1 accumulation in the diabetic retina when compared with WT diabetic counterparts (p<0.01). Diabetes-related increases in M{\"u}ller glial GFAP levels and loss of Kir4.1 at the vascular end-feet were significantly prevented by GLO1 overexpression (p<0.05) at both 12- and 24-week time points. GLO1 diabetic animals showed fewer acellular capillaries than WT diabetic animals (p<0.001) at 24 weeks' diabetes. Conclusions/interpretation: Detoxification of MG reduces AGE adduct accumulation, which, in turn, can prevent formation of key retinal neuroglial and vascular lesions as diabetes progresses. MG-derived AGEs play an important role in diabetic retinopathy.",
keywords = "AGEs, Diabetic complications, Diabetic retinopathy, Glyoxalase 1, Methylglyoxal, Pathogenesis, Retina",
author = "Berner, {A. K.} and O. Brouwers and R. Pringle and I. Klaassen and L. Colhoun and C. McVicar and S. Brockbank and Curry, {J. W.} and T. Miyata and M. Brownlee and Schlingemann, {R. O.} and C. Schalkwijk and Stitt, {A. W.}",
year = "2012",
month = "3",
doi = "10.1007/s00125-011-2393-0",
language = "English (US)",
volume = "55",
pages = "845--854",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

AU - Berner, A. K.

AU - Brouwers, O.

AU - Pringle, R.

AU - Klaassen, I.

AU - Colhoun, L.

AU - McVicar, C.

AU - Brockbank, S.

AU - Curry, J. W.

AU - Miyata, T.

AU - Brownlee, M.

AU - Schlingemann, R. O.

AU - Schalkwijk, C.

AU - Stitt, A. W.

PY - 2012/3

Y1 - 2012/3

N2 - Aims/hypothesis: Methylglyoxal (MG) is an important precursor for AGEs. Normally, MG is detoxified by the glyoxalase (GLO) enzyme system (including component enzymes GLO1 and GLO2). Enhanced glycolytic metabolism in many cells during diabetes may overpower detoxification capacity and lead to AGE-related pathology. Using a transgenic rat model that overexpresses GLO1, we investigated if this enzyme can inhibit retinal AGE formation and prevent key lesions of diabetic retinopathy. Methods: Transgenic rats were developed by overexpression of full length GLO1. Diabetes was induced in wild-type (WT) and GLO1 rats and the animals were killed after 12 or 24 weeks of hyperglycaemia. N ε-(Carboxyethyl)lysine (CEL), N ε-(carboxymethyl) lysine (CML) and MG-derived-hydroimidazalone-1 (MG-H1) were determined by immunohistochemistry and by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MSMS). Müller glia dysfunction was determined by glial fibrillary acidic protein (GFAP) immunoreactivity and by spatial localisation of the potassium channel Kir4.1. Acellular capillaries were quantified in retinal flat mounts. Results: GLO1 overexpression prevented CEL and MG-H1 accumulation in the diabetic retina when compared with WT diabetic counterparts (p<0.01). Diabetes-related increases in Müller glial GFAP levels and loss of Kir4.1 at the vascular end-feet were significantly prevented by GLO1 overexpression (p<0.05) at both 12- and 24-week time points. GLO1 diabetic animals showed fewer acellular capillaries than WT diabetic animals (p<0.001) at 24 weeks' diabetes. Conclusions/interpretation: Detoxification of MG reduces AGE adduct accumulation, which, in turn, can prevent formation of key retinal neuroglial and vascular lesions as diabetes progresses. MG-derived AGEs play an important role in diabetic retinopathy.

AB - Aims/hypothesis: Methylglyoxal (MG) is an important precursor for AGEs. Normally, MG is detoxified by the glyoxalase (GLO) enzyme system (including component enzymes GLO1 and GLO2). Enhanced glycolytic metabolism in many cells during diabetes may overpower detoxification capacity and lead to AGE-related pathology. Using a transgenic rat model that overexpresses GLO1, we investigated if this enzyme can inhibit retinal AGE formation and prevent key lesions of diabetic retinopathy. Methods: Transgenic rats were developed by overexpression of full length GLO1. Diabetes was induced in wild-type (WT) and GLO1 rats and the animals were killed after 12 or 24 weeks of hyperglycaemia. N ε-(Carboxyethyl)lysine (CEL), N ε-(carboxymethyl) lysine (CML) and MG-derived-hydroimidazalone-1 (MG-H1) were determined by immunohistochemistry and by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MSMS). Müller glia dysfunction was determined by glial fibrillary acidic protein (GFAP) immunoreactivity and by spatial localisation of the potassium channel Kir4.1. Acellular capillaries were quantified in retinal flat mounts. Results: GLO1 overexpression prevented CEL and MG-H1 accumulation in the diabetic retina when compared with WT diabetic counterparts (p<0.01). Diabetes-related increases in Müller glial GFAP levels and loss of Kir4.1 at the vascular end-feet were significantly prevented by GLO1 overexpression (p<0.05) at both 12- and 24-week time points. GLO1 diabetic animals showed fewer acellular capillaries than WT diabetic animals (p<0.001) at 24 weeks' diabetes. Conclusions/interpretation: Detoxification of MG reduces AGE adduct accumulation, which, in turn, can prevent formation of key retinal neuroglial and vascular lesions as diabetes progresses. MG-derived AGEs play an important role in diabetic retinopathy.

KW - AGEs

KW - Diabetic complications

KW - Diabetic retinopathy

KW - Glyoxalase 1

KW - Methylglyoxal

KW - Pathogenesis

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=84856729229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856729229&partnerID=8YFLogxK

U2 - 10.1007/s00125-011-2393-0

DO - 10.1007/s00125-011-2393-0

M3 - Article

C2 - 22143324

AN - SCOPUS:84856729229

VL - 55

SP - 845

EP - 854

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 3

ER -